This paper is in the following e-collection/theme issue:

Decision Support for Health Professionals (1506) Clinical Information and Decision Making (1865) Machine Learning (2025) Cancer Prognosis Models and Machine Learning (60) Innovations and Technology for Cancer Prevention and Screening (196) Chronic Conditions (418) Gastroenterology and Hepatology (114)

Published on in Vol 13 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/78354, first published .
Development and Validation of an Extra Spindle Pole Bodies–like 1–Based Diagnostic and Prognostic Model for Hepatitis B Virus–Related Hepatocellular Carcinoma: Retrospective Cohort Study

Development and Validation of an Extra Spindle Pole Bodies–like 1–Based Diagnostic and Prognostic Model for Hepatitis B Virus–Related Hepatocellular Carcinoma: Retrospective Cohort Study

Development and Validation of an Extra Spindle Pole Bodies–like 1–Based Diagnostic and Prognostic Model for Hepatitis B Virus–Related Hepatocellular Carcinoma: Retrospective Cohort Study

Authors of this article:

Lu-Huai Feng1 Author Orcid Image ;   Hengkai Liang1 Author Orcid Image ;   Bobin Hu1 Author Orcid Image ;   Lu Wei1 Author Orcid Image ;   Qingmei Li1 Author Orcid Image ;   Tumei Su1 Author Orcid Image ;   Qianbing Yin1 Author Orcid Image ;   Yanfei Feng1 Author Orcid Image ;   Long Huang1 Author Orcid Image ;   Hongqian Liang1 Author Orcid Image ;   Minghua Su1 Author Orcid Image ;   Jianning Jiang1, 2, 3 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Lu-Huai Feng   1 * , MD ;   Hengkai Liang   1 * , MM ;   Bobin Hu   1 , MD ;   Lu Wei   1 , MM ;   Qingmei Li   1 , MM ;   Tumei Su   1 , MM ;   Qianbing Yin   1 , MM ;   Yanfei Feng   1 , MM ;   Long Huang   1 , MM ;   Hongqian Liang   1 , MM ;   Minghua Su   1 , MD ;   Jianning Jiang   1, 2, 3 , MD

1 Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, China

2 Key Laboratory of Early Prevention and Treatment of Regional High Incidence Tumors (Guangxi Medical University), Ministry of Education, Nanning, China

3 Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Nanning, China

*these authors contributed equally

Corresponding Author:

  • Jianning Jiang, MD
  • Department of Infectious Diseases
  • The First Affiliated Hospital of Guangxi Medical University
  • 6 Shuangyong Road
  • Nanning 530021
  • China
  • Phone: 86 0771-5719573
  • Email: gxjjianning@163.com